Theo from United Kingdom

Registered at the short selling broker Skilling, 5 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

Banco Santander SA (SAN) shares information

Banco Santander SA


24h Change

-0.50 %

SAN

Live rate: Market closed

Stock data per Wednesday 21 Oct, 2020

SAN
New York Stock Exchange
2
2.01
1.99
-0.01 (-0.50%)
US Market is closed

Live Stock price in graph for Banco Santander SA (SAN)

  • Latest Volume

    5,325,872 (-48.8 %)

  • Volume prev. day

    10,402,790

  • Avg. daily volume

    8,956,731

  • Market cap

    33,053,242,454

  • P/E ratio

    -4

  • Today high

    2.03

  • Today low

    1.98

  • 52 week high

    4.42

  • 52 week low

    1.78

  • YTD Change

    n/a

Quick links

Broker recommendations for Banco Santander SA

The Banco Santander SA stock is rated at 1.76 (on a scale 1-3, where 1 is ‘strong buy‘ and 3 is ‘strong sell‘) from Wednesday 14 October, 2020 by a total of 25 brokers. This means that the consensus of the 25 different brokers is leaning toward to moderate buy/hold.

Sell
4 (16%)
Underweight
1 (4%)
Hold
9 (36%)
Overweight
1 (4%)
Buy
10 (40%)

Price target by analysts

The 23 latest analyst estimates, per Monday 19 October, 2020, show the following high, low and average price targets.
Target Average: 2.74 USD
Target High: 3.69 USD
Target Low: 1.89 USD

 

Latest news about Banco Santander SA

Below you can find the most recent news posts about Banco Santander SA, primarily from US and UK based news sources.

Graft-Versus-Host Disease (GVHD) Market to Worth USD 656.00 million by 2026, Top Leading Players Sanofi (France), Novartis AG (Switzerland), Neovii Biotech GmbH (Germany), Merck & Co., Inc. (US)

Wednesday, 21 October 2020, 20:51:04
Global Graft-Versus-Host Disease (GVHD) Market is expected to rise gradually to an estimated value of USD 656.00 million by 2026, registering a CAGR of 6.05% in the forecast period of 2019-2026 with the annual sales of USD 410.00 million in
— OpenPR


Genetic Disorders Market to Grow at a CAGR of 13.68%, Leading Players Amicus Therapeutics, Inc.; Alexion Pharmaceuticals, Inc.; Sanofi; Takeda Pharmaceutical Company Limited; Vertex Pharmaceuticals Incorporated

Wednesday, 21 October 2020, 20:40:14
Genetic Disorders Market is expected to register a healthy CAGR of 13.68% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be
— OpenPR


Veterinary Reference Laboratory Market 2020 Global Industry Growth, Share, Size, Trends, COVID-19 Impact Analysis and 2027 Forecasts Report – Sanofi, Idexx Laboratories, Mars, GD, Zoetis, Phoenix Lab, Virbac

Wednesday, 21 October 2020, 15:43:35
A complete discussion about numerous market related topics in this Veterinary Reference Laboratory Market research report is sure to aid the client in studying the market on competitive landscape. With the use of few steps or the combination of several
— OpenPR


Diabetes Care Drugs Market 2020 COVID-19 Impact, Share, Trend, Segmentation and Forecast to 2027 |Pfizer, Sanofi, Novartis, Abbott, GSK, Merck, Roche, Eli Lilly, B. Braun Melsungen, AstraZeneca, Bayer, DexCom

Wednesday, 21 October 2020, 14:41:24
Diabetes Care Drugs market is expected to reach USD +94 billion by the end of 2027 with +6% CAGR during forecast period 2020-2027. The latest report devised by the analysts at Market Research Inc accumulates the current working of the market
— OpenPR


Obsessive Compulsive Disorder (OCD) Drug Market : Research Report And Predictive Business Strategy 2020 – 2026 | Emerging Players – Abbott, Pfizer Inc., Merck & Co., Inc., Sanofi, Novartis AG

Wednesday, 21 October 2020, 14:35:41
Obsessive Compulsive Disorder (OCD) Drug Market research report comprises of several parameters which are thoroughly studied by the experts. Market research analysis and data lend a hand to businesses for the planning of production, product launches, costing, inventory, purchasing and
— OpenPR


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €/$ 20
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have SAN available or trade one of the many other CFD stocks they have.
Risk warning: 75% of retail investor accounts lose money when trading CFDs with Capital.